Immunai CTO and Co-Founder Luis Voloch on Usi...

Enterprises are moving from AI pilots to full‑scale AI factories that turn data into trusted digital intelligence. Red Hat CTO Chris Wright and NVIDIA’s Justin Boitano unpack the "five‑layer cake" AI factory stack, from accelerated hardware and hybrid cloud infrastructure to mode ...  Show more

AI is reshaping electricity demand. What does increased demand, and the shape of that demand, mean for the electric grid? Ben Sooter, Director of R&D at EPRI joins the podcast to explain why most of an AI model’s lifetime energy use comes from inference rather than training, and ...  Show more

The immu-knowledge-ists deconstruct the holy grail of oncologists, cancer immunotherapy, and the exciting development of CAR T cells and how they work.

Hosts: Vincent Racaniello

According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to deve ...

00:47 An edited genetic code that prevents viral infectionResearchers have engineered bacteria with synthetic genomes to be immune to viral infection. The team streamlined the bacteria’s genetic code, and re-engineered the protein-producing machinery to insert the wrong amino aci ...  Show more

A brain-computer interface allows a severely paralysed patient not only to move and use a robotic arm, but also to feel the sensations as the mechanical hand clasps objects . We hear from Jennifer Collinger at Pittsburgh University’s Rehab Neural Engineering Labs. And Nathan Cope ...  Show more